News & Insights
Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.
PUBLICATION
The neuropharmacological substrates of nicotine reward: reinforcing versus reinforcement-enhancing effects of nicotine.
PUBLICATION
Pharmacological characterization of harmaline-induced tremor activity in mice.
PUBLICATION
Systematic behavioral evaluation of Huntington’s disease transgenic and knock-in mouse models.
PUBLICATION
GABAa receptor α1 subunit (Gabra1) knockout mice: review and new results. In Mutant and Transgenic Tools in Modeling Brain Disorders
PUBLICATION
Loss of the putative catalytic domain of HDAC4 leads to reduced thermal nociception and seizures while allowing normal bone development.
PUBLICATION
Translational aspects of pharmacological research into anxiety disorders: the stress-induced hyperthermia (SIH) paradigm.
PUBLICATION
Cognitive endpoints as disease biomarkers: optimizing the congruency of preclinical models to the clinic.
PUBLICATION
Learning and memory impairment in Eph receptor A6 knockout mice.
PUBLICATION
